Clinical Study
Prognostic Factors in Tuberculosis Related Mortalities in Hospitalized Patients
Table 2
Patient particulars on admission with odds ratio*.
| | Factor | Cases | Controls | | OR (95% CI) |
| | Female sex, (%) | 28 (46.6) | 24 (40) | 0.46 | 0.76 (0.36–1.57) | | Age, mean years (range) | 47 (14–95) | 32.97 (15–75) | 0.04 | n/a | | Weight, mean kg (range) | 36.82 (28–65) | 48.83 (25–81) | <0.01 | n/a | | Smokers, (%) | 32 (53.3) | 11 (18.3) | <0.01 | 0.19 (0.08–0.44) | | Past TB history, (%) | 32 (53.3) | 19 (31.6) | 0.04 | 0.32 (0.15–0.71) | | Pulmonary TB, (%) | 39 (65) | 16 (26.6) | <0.01 | 0.19 (0.09–0.42) | | Bilateral lung involvement, (%) | 31 (51.6) | 7 (11.6) | <0.01 | 8.09 (3.17–20.6) | | Not taking ATT, (%) | 48 (80) | 04 (6.6) | <0.01 | 56 (16.9–185.0) | | Smear positive, | 15/25 | 39/56 | <0.01 | n/a | | HIV positive, (%) | 1/54 | 00 | 0.02 | n/a | | TLC ×109/L, mean | 12.91 | 8.27 | <0.01 | n/a | | Neutrophils, mean % | 82.60 | 77.07 | 0.02 | n/a | | Lymphocytes, mean % | 12.49 | 18.27 | <0.01 | n/a | | Serum protein U/L, mean | 5.01 | 6.48 | <0.01 | n/a |
|
|
OR: odds ratio; CI: confidence interval; TB: tuberculosis; ATT: anti-tuberculosis treatment; HIV: human immunodeficiency virus; TLC: total leukocyte count; n/a: not applicable.
|
